Chinese coronavirus vaccine shows 50% efficacy in Brazil

The Chinese-developed Coronavac COVID-19 vaccine has demonstrated a 50 percent efficacy following tests in Brazil, the organization in charge of its production in the South American country said on Tuesday.


Sinovac, AstraZeneca seek vaccine approval in Brazil

The manufacturers of two COVID-19 vaccines developed by Chinese pharmaceutical firm Sinovac and Oxford-AstraZeneca filed the first applications Friday for regulatory approval in hard-hit Brazil, officials said.


Chinese vaccine seeks regulatory approval in Brazil

Chinese pharmaceutical firm Sinovac's local partner in Brazil applied Friday for emergency authorization for its COVID-19 vaccine, the first to seek regulatory approval in the hard-hit country, officials said.

Diseases, Conditions, Syndromes

Wiser resolutions? Lessons from COVID's unfulfilled ones

She'd wanted to frame and hang them—just three printed pictures that had been sitting in Lucy O'Donoghue's suburban Atlanta house since the year began. That's all. Yet with a full-time job and two small kids, she hadn't ...